Cargando…
Randomized controlled comparison of agomelatine and escitalopram: Concerns about study design and methods
Autores principales: | Pal, Sutanaya, Pinto, Ekta Franscina, Raut, Nitin B., Banwari, Girish, Andrade, Chittaranjan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5020778/ https://www.ncbi.nlm.nih.gov/pubmed/27651715 http://dx.doi.org/10.4103/0976-500X.189688 |
Ejemplares similares
-
Questionable usefulness of the everyday abilities scale of India to screen for dementia
por: Sahoo, Swapnajeet, et al.
Publicado: (2017) -
Interferon-Related Depression: A Primer on Mechanisms, Treatment, and Prevention of a Common Clinical Problem
por: Pinto, Ekta Franscina, et al.
Publicado: (2016) -
Development & validation of the Chandigarh autism screening instrument
por: Andrade, Chittaranjan, et al.
Publicado: (2019) -
Agomelatine Augmentation of Escitalopram Therapy in Treatment-Resistant Obsessive-Compulsive Disorder: A Case Report
por: De Berardis, Domenico, et al.
Publicado: (2012) -
Treatment compliance and noncompliance in psychosis: Methodological issues
por: Pinto, Ekta Franscina, et al.
Publicado: (2017)